MicroRNA (miRNA) in Cancers
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Molecular Cancer Biology".
Deadline for manuscript submissions: closed (31 October 2025) | Viewed by 1383
Special Issue Editors
Interests: miRNAs; cancer; personalized medicine
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
MicroRNAs (miRNAs) are small, non-coding RNA molecules that play a crucial role in regulating gene expression. In cancer, miRNAs function as both tumor suppressors and oncogenes, influencing cancer development, progression, and metastasis. Aberrant miRNA expression can lead to the dysregulation of critical pathways involved in cell proliferation, apoptosis, and differentiation. Recent research highlights the potential of miRNAs as diagnostic biomarkers and therapeutic targets. As our understanding of miRNA biology deepens, their integration into clinical practice offers promising avenues for improving cancer diagnosis, treatment, and patient outcomes. We invite you to contribute to the burgeoning field of microRNAs (miRNAs) in cancer research and to publish in this Special Issue innovative studies that deepen our understanding of miRNA biology and explore their clinical applications. Your research could pave the way for novel diagnostic tools and therapeutic strategies, transforming the realm of personalized medicine. Join us in this exciting endeavor to harness the power of miRNAs for improving cancer diagnosis, treatment, and patient outcomes.
Dr. Jochen Maurer
Prof. Dr. Elmar Stickeler
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- miRNAs
- cancer
- diagnostics
- tumor progression
- metastasis
- therapeutic targets
- personalized medicine
- pathways
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
